Danaher Provides Update On First Quarter 2020 Financial Performance And Schedules First Quarter Earnings Conference Call

Danaher Provides Update On First Quarter 2020 Financial Performance And Schedules First Quarter Earnings Conference Call WASHINGTON, April 13, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher” or “the Company”) announced today that for the quarter ended April 3, 2020 it expects revenue growth of approximately 3.0% and non-GAAP core revenue growth of approximately 4.5%.... Read more

Danaher Completes Acquisition Of The Biopharma Business Of General Electric Life Sciences; Business Will Be Called Cytiva

Danaher Completes Acquisition Of The Biopharma Business Of General Electric Life Sciences; Business Will Be Called Cytiva WASHINGTON, March 31, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”) announced today the completion of its acquisition of the Biopharma business from General Electric Company’s (NYSE: GE) Life Sciences division. As part of Danaher, the business will... Read more

Danaher Receives Clearance From U.S. Federal Trade Commission For The Acquisition Of The Biopharma Business Of General Electric Life Sciences

Danaher Receives Clearance From U.S. Federal Trade Commission For The Acquisition Of The Biopharma Business Of General Electric Life Sciences WASHINGTON, March 19, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”) announced today that the U.S. Federal Trade Commission (the “FTC”) has accepted the proposed consent order in connection with Danaher’s definitive agreement with General... Read more

Danaher Reports Fourth Quarter and Full Year 2019 Results

WASHINGTON, Jan. 30, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the fourth quarter and full year 2019.  All results in this release reflect only continuing operations unless otherwise noted. For the quarter ended December 31, 2019, net earnings were $792.9 million, or $1.07 per diluted share which represents a... Read more

Danaher Announces Updated Time For Fourth Quarter 2019 Earnings Conference Call

WASHINGTON, Jan. 23, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that it has changed the time for its fourth quarter 2019 conference call and webcast. The call will now begin at 7:30 a.m. ET on Thursday, January 30, 2020. The call and an accompanying slide presentation will be webcast on the “Investors” section... Read more

Danaher CEO To Comment On Financial Performance

WASHINGTON, Jan. 13, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) announced today that its President and Chief Executive Officer, Thomas P. Joyce, Jr., will comment tomorrow on the Company’s fourth quarter 2019 performance in a presentation at the J.P. Morgan Healthcare Conference in San Francisco, California at 8:00 a.m. PT. Mr. Joyce will communicate... Read more

Danaher Schedules Fourth Quarter 2019 Earnings Conference Call

WASHINGTON, Jan. 7, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the fourth quarter 2019 on Thursday, January 30, 2020 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section... Read more